Terms: = Colorectal cancer AND PSA AND Diagnosis
87 results:
1. "Shared decision-making" for prostate cancer screening: Is it a marker of quality preventative healthcare?
Golijanin B; Bhatt V; Homer A; Malshy K; Ochsner A; Wales R; Khaleel S; Mega A; Pareek G; Hyams E
Cancer Epidemiol; 2024 Feb; 88():102492. PubMed ID: 38056246
[TBL] [Abstract] [Full Text] [Related]
2. Latin America and the Caribbean Code Against cancer 1st Edition: Medical interventions including hormone replacement therapy and cancer screening.
Baena A; Paolino M; Villarreal-Garza C; Torres G; Delgado L; Ruiz R; Canelo-Aybar C; Song Y; Feliu A; Maza M; Jeronimo J; Espina C; Almonte M
Cancer Epidemiol; 2023 Oct; 86 Suppl 1():102446. PubMed ID: 37852728
[TBL] [Abstract] [Full Text] [Related]
3. Screening practices of cancer survivors and individuals whose family or friends had a cancer diagnoses-a nationally representative cross-sectional survey in Japan (INFORM Study 2020).
Akiyama M; Ishida N; Takahashi H; Takahashi M; Otsuki A; Sato Y; Saito J; Yaguchi-Saito A; Fujimori M; Kaji Y; Shimazu T;
J Cancer Surviv; 2023 Jun; 17(3):663-676. PubMed ID: 37041402
[TBL] [Abstract] [Full Text] [Related]
4. The survival of the prostate cancer patients with secondary colorectal cancer: a study based on a SEER database from southern China.
Lin L; Huang L; Li YL; Shan H
Eur Rev Med Pharmacol Sci; 2023 Feb; 27(3):1128-1133. PubMed ID: 36808373
[TBL] [Abstract] [Full Text] [Related]
5. High Throughput Isolation and Data Independent Acquisition Mass Spectrometry (DIA-MS) of Urinary Extracellular Vesicles to Improve Prostate cancer diagnosis.
Zhang H; Zhang GY; Su WC; Chen YT; Liu YF; Wei D; Zhang YX; Tang QY; Liu YX; Wang SZ; Li WC; Wesselius A; Zeegers MP; Zhang ZY; Gu YH; Tao WA; Yu EY
Molecules; 2022 Nov; 27(23):. PubMed ID: 36500247
[TBL] [Abstract] [Full Text] [Related]
6. A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study.
Bancroft EK; Page EC; Brook MN; Thomas S; Taylor N; Pope J; McHugh J; Jones AB; Karlsson Q; Merson S; Ong KR; Hoffman J; Huber C; Maehle L; Grindedal EM; Stormorken A; Evans DG; Rothwell J; Lalloo F; Brady AF; Bartlett M; Snape K; Hanson H; James P; McKinley J; Mascarenhas L; Syngal S; Ukaegbu C; Side L; Thomas T; Barwell J; Teixeira MR; Izatt L; Suri M; Macrae FA; Poplawski N; Chen-Shtoyerman R; Ahmed M; Musgrave H; Nicolai N; Greenhalgh L; Brewer C; Pachter N; Spigelman AD; Azzabi A; Helfand BT; Halliday D; Buys S; Ramon Y Cajal T; Donaldson A; Cooney KA; Harris M; McGrath J; Davidson R; Taylor A; Cooke P; Myhill K; Hogben M; Aaronson NK; Ardern-Jones A; Bangma CH; Castro E; Dearnaley D; Dias A; Dudderidge T; Eccles DM; Green K; Eyfjord J; Falconer A; Foster CS; Gronberg H; Hamdy FC; Johannsson O; Khoo V; Lilja H; Lindeman GJ; Lubinski J; Axcrona K; Mikropoulos C; Mitra AV; Moynihan C; Ni Raghallaigh H; Rennert G; Collier R; ; Offman J; Kote-Jarai Z; Eeles RA
Lancet Oncol; 2021 Nov; 22(11):1618-1631. PubMed ID: 34678156
[TBL] [Abstract] [Full Text] [Related]
7. Prostate cancer Incidence and Mortality Following a Negative Biopsy in a Population Undergoing psa Screening.
Pierre-Victor D; Parnes HL; Andriole GL; Pinsky PF
Urology; 2021 Sep; 155():62-69. PubMed ID: 34186135
[TBL] [Abstract] [Full Text] [Related]
8. Trends in population-based cancer survival in Slovenia.
Zadnik V; Zagar T; Lokar K; Tomsic S; Konjevic AD; Zakotnik B
Radiol Oncol; 2021 Jan; 55(1):42-49. PubMed ID: 33885247
[TBL] [Abstract] [Full Text] [Related]
9. Body size throughout the life-course and incident benign prostatic hyperplasia-related outcomes and nocturia.
Khan S; Wolin KY; Pakpahan R; Grubb RL; Colditz GA; Ragard L; Mabie J; Breyer BN; Andriole GL; Sutcliffe S
BMC Urol; 2021 Mar; 21(1):47. PubMed ID: 33773592
[TBL] [Abstract] [Full Text] [Related]
10. Factors Associated with cancer Screening Among Hopi Men.
Batai K; Sanderson PR; Hsu CH; Joshweseoma L; Russell D; Joshweseoma L; Ojeda J; Burhansstipanov L; Brown SR; Ami D; Saboda K; Harris RB
J Cancer Educ; 2022 Aug; 37(4):915-923. PubMed ID: 33083892
[TBL] [Abstract] [Full Text] [Related]
11. [Metachronous Pubic Bone Metastases from Synchronous Double cancer with Prostate and Ascending Colon cancers : A Case Report].
Ito H; Hishida S; Taniguchi T; Kato D; Takai M; Iinuma K; Muramatsu-Maekawa Y; Kato T; Nakane K; Mizutani K; Tsuchiya T; Takahashi T; Suzui N; Miyazaki T; Koie T
Hinyokika Kiyo; 2020 Aug; 66(8):273-277. PubMed ID: 32882125
[TBL] [Abstract] [Full Text] [Related]
12. Mismatch repair deficiency in metastatic prostate cancer: Response to PD-1 blockade and standard therapies.
Graham LS; Montgomery B; Cheng HH; Yu EY; Nelson PS; Pritchard C; Erickson S; Alva A; Schweizer MT
PLoS One; 2020; 15(5):e0233260. PubMed ID: 32453797
[TBL] [Abstract] [Full Text] [Related]
13. Incidental Finding of Colon Carcinoma Related to High Uptake in 18F-PSMA-1007 PET.
Arçay A; Eiber M; Langbein T
Clin Nucl Med; 2020 Jul; 45(7):561-562. PubMed ID: 32433166
[TBL] [Abstract] [Full Text] [Related]
14. Substantial tumor regression in prostate cancer patient with extensive skeletal metastases upon Immunotherapy (APCEDEN): A case report.
Sharan B; Chiliveru S; Bagga J; Kohli S; Bharadwaj A; Vaid AK; Kumar C
Medicine (Baltimore); 2020 Feb; 99(8):e18889. PubMed ID: 32080073
[TBL] [Abstract] [Full Text] [Related]
15. Association of Baseline Prostate-Specific Antigen Level With Long-term diagnosis of Clinically Significant Prostate cancer Among Patients Aged 55 to 60 Years: A Secondary Analysis of a Cohort in the Prostate, Lung, colorectal, and Ovarian (PLCO) cancer Screening Trial.
Kovac E; Carlsson SV; Lilja H; Hugosson J; Kattan MW; Holmberg E; Stephenson AJ
JAMA Netw Open; 2020 Jan; 3(1):e1919284. PubMed ID: 31940039
[TBL] [Abstract] [Full Text] [Related]
16. [A Case of Rectum-Infiltrating Prostate cancer Mimicking Prostate-Infiltrating Rectal cancer].
Hishiki K; Takada H; Nakashima Y; Kohei N; Nishio Y; Muro H; Ohata K; Yoshimura K
Hinyokika Kiyo; 2018 Sep; 64(9):373-377. PubMed ID: 30369229
[TBL] [Abstract] [Full Text] [Related]
17. Extended follow-up for prostate cancer incidence and mortality among participants in the Prostate, Lung, colorectal and Ovarian randomized cancer screening trial.
Pinsky PF; Miller E; Prorok P; Grubb R; Crawford ED; Andriole G
BJU Int; 2019 May; 123(5):854-860. PubMed ID: 30288918
[TBL] [Abstract] [Full Text] [Related]
18. Early Epigenetic Markers for Precision Medicine.
Dumitrescu RG
Methods Mol Biol; 2018; 1856():3-17. PubMed ID: 30178243
[TBL] [Abstract] [Full Text] [Related]
19. Sigmoid Colon Adenocarcinoma with Isolated Loss of PMS2 Presenting in a Patient with Synchronous Prostate cancer with Intact MMR: diagnosis and Analysis of the Family Pedigree.
Liu W; Zhang D; Tan SA; Liu X; Lai J
Anticancer Res; 2018 Aug; 38(8):4847-4852. PubMed ID: 30061258
[TBL] [Abstract] [Full Text] [Related]
20. [A Case of Synchronous Quadruple cancers Treated with Neoadjuvant Chemotherapy Followed by Surgery].
Muramoto K; Miyake T; Shimizu T; Sonoda H; Ueki T; Terada Y; Mori H; Maehira H; Takebayashi K; Kaida S; Iida H; Yamaguchi T; Tani M
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1871-1873. PubMed ID: 29394804
[TBL] [Abstract] [Full Text] [Related]
[Next]
